Sensex, Nifty Erase Gains Weighed Down By Selling In Private Sector Lenders
The S&P BSE Sensex and NSE Nifty 50 indexes erased gains in late morning deals as private sector lenders, pharma and metal shares came under selling pressure. The benchmarks opened on a positive note wherein the Sensex surged as much as 276 points and Nifty 50 index moved above its important psychological level of 10,550. Gains in Asian Paints, ITC, HDFC and Tata Consultancy Services were offset with losses in ICICI Bank, Bharti Airtel, Axis Bank and HCL Technologies.
As of 11:38 am, the Sensex was down 64 points or 0.18 per cent at 35,366 and Nifty was at 10,456, down 15 points or 0.14 per cent,
Six of 11 sector gauges compiled by the National Stock Exchange were trading ower led by the Nifty Private Bank index's nearly 1 per cent loss. Nifty Bank, Pharma, Metal and Realty indexes were trading with a negative bias.
On the other hand, Nifty FMCG index was top gainer, up 0.95 per cent.
Mid- and small-cap shares were in-line with their larger peers as both the Nifty Midcap 100 and Nifty Smallcap 100 indexes rose 0.1 per cent.
IndusInd Bank was top Nifty loser, the stock fell 2.3 per cent to Rs 508. Power Grid, ONGC, ICICI Bank, Cipla, Axis Bank, Bharti Airtel, Bharat Petroleum, UPL, HCL Technologies, Bajaj Finserv and Hindalco also fell between 1.3-2 per cent each.
On the flipside, Asian Paints surged nearly 8 per cent to hit an intraday high of Rs 1,813.10 on BSE a day after company reported a 5 per cent, year-on-year, decline in net profit at Rs 452 crore.
Hero MotoCorp, Tata Motors, ITC, Titan, Bajaj Auto, Nestle India, HDFC, TCS and Vedanta were also among the gainers.
The overall market breadth was positive as 1,379 shares were advancing while 1,055 were declining on the BSE.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.